Furthermore, one study showed that by encouraging repressive H2A ubiquitination in CCA cells, BMI1 suppresses chemokines that recruit CD8+ T cells, implicating a potential novel combination therapy of anti‐PD‐1 and BMI1 inhibitors for CCA.401. This evidence concerns the gene BMI1 and cholangiocarcinoma.